New Psoriatic Arthritis Treatments 2021



Article last updated on 7/29/2021


What is Psoriatic Arthritis?

Psoriatic arthritis is a type of arthritis that can occur in people who have the skin condition psoriasis. It is a chronic inflammatory disease that causes the joints to become swollen, stiff and painful. Approximately 30 percent of people with psoriasis develop psoriatic arthritis.1


What are Psoriatic Arthritis symptoms?

Psoriatic Arthritis develops either slowly, with mild symptoms, or rapidly and severely. How severe the disease is varies from person to person.1

Common symptoms include:1

  • Fatigue
  • Tenderness, pain and swelling over tendons
  • Swollen fingers and toes
  • Stiffness, pain, throbbing, swelling and tenderness in one or more joints
  • Reduced range of motion
  • Morning stiffness and tiredness
  • Nail changes, such as pitting or separation from the nail bed
  • Redness and pain of the eye (uveitis)

Treatment for Psoriatic Arthritis<

There are different psoriatic arthritis medications. Together with your doctor you will decide what the best psoriatic arthritis treatment is for you. The main treatments for psoriatic arthritis include:2

  • Non-steroidal anti-inflammatory drugs (NSAIDs), which are used for psoriatic arthritis pain management and which help reduce inflammation.
  • Corticosteroids, which work anti-inflammatory.
  • Disease-modifying anti-rheumatic drugs (DMARDs), which help reduce inflammation and can stop psoriatic arthritis from worsening.
  • Biological therapies are psoriatic arthritis meds that can stop particular chemicals in the blood from causing the immune system to attack the lining of the joints.

What are Psoriatic Arthritis medicine side effects?

It is helpful to learn more about the side effects of treatment upfront, so you know what to expect. Your treating physician can discuss this with you and help you manage your wellbeing during and after treatment. Because many medications for psoriatic arthritis suppress the immune system, there is an increased risk of infection.3


What are new Psoriatic Arthritis treatments?

There are several approved new treatments for Psoriatic Arthritis. Here are some of them:


Tremfya (guselkumab)4,5

Tremfya (guselkumab) is an interleukin-23 antagonist indicated for the treatment of adult patients with:

  • active psoriatic arthritis
  • moderate-to-severe plaque psoriasis who are candidates for systemic therapy or light therapy

Tremfya (guselkumab) was approved for the treatment of adult patients with active psoriatic arthritis by:

  • The Food and Drug Administration (FDA), USA on July 14, 2020.

Taltz (ixekizumab)6,7

Taltz (ixekizumab) is an interleukin-17A antagonist indicated for the treatment of people with:

  • active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drug (DMARD) therapies.
  • moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Taltz (ixekizumab) was approved for the treatment of adult patients with active psoriatic arthritis by:

  • The Food and Drug Administration (FDA), USA on December 1, 2017.
  • The European Medical Agency (EMA) on January 11, 2018.

Cosentyx (secukinumab)8,9

Cosentyx (secukinumab) is an interleukin-17A antagonist indicated for the treatment of adults with:

  • active psoriatic arthritis
  • moderate to severe plaque psoriasis
  • active ankylosing spondylitis (AS)

Cosentyx (secukinumab) was approved for the treatment of active psoriatic arthritis by:

  • The European Medicines Agency (EMA) on November 23, 2015.
  • The Food and Drug Administration (FDA), USA on January 15, 2016.
  • Health Canada on April 27, 2016.
  • Therapeutic Goods Administration (TGA), Australia on November 14, 2016.
  • MedSafe, New Zealand on May 1, 2021.

Stelara (ustekinumab)10,11

Stelara (ustekinumab) is an interleukin-12 and interleukin-23 antagonist (immunosuppressant) indicated for the treatment of:

  • active psoriatic arthritis in adults, with or without another medicine called methotrexate.
  • moderate or severe plaque psoriasis in adults and children aged 6 years and older, whose condition has not improved with, or who cannot use, other systemic (whole-body) psoriasis treatments or phototherapy (treatment using ultraviolet light alone or with pills).
  • moderately to severely active Crohn's disease in adults, after other medicines have been tried without success
  • moderately to severely active ulcerative colitis in adults, after other medicines have been tried without success.
  • Stelara (ustekinumab) was approved for the treatment of active psoriatic arthritis by:
  • The European Medicines Agency (EMA) on September 23, 2013.
  • The Food and Drug Administration (FDA), USA on September 23, 2013.

  • If you are trying to access a treatment for Psoriatic Arthritis that is approved outside of your country of residence, we might be able to help you access it with the help of your treating doctor. You can read more about the medicines we can help you access and their price below:



    Why access and buy Psoriatic Arthritis treatments with TheSocialMedwork?

    TheSocialMedwork is registered in The Hague with the Dutch Ministry of Health as an independent medicines intermediary (registration number 6730 BEM) and as an international pharmacy (registration number 16258 G). We have helped patients from over 85 countries to access thousands of medicines that are not yet approved in their home country, including patients suffering from Psoriatic Arthritis. With a prescription from your treating doctor, you can count on our expert team to safely and legally guide you to access Psoriatic Arthritis medicines in your country. If you or someone you know are looking to access a medicine that is not yet approved where you live, we will support you. Contact us for more information.


    References:

    1. NHS.uk
    2. psoriasis.org
    3. Aarthritis.org
    4. Tremfya (guselkumab)
    5. FDA Tremfya
    6. Taltz (ixekizumab)
    7. FDA Taltz
    8. Cosentyx (secukinumab)
    9. FDA Cosentyx
    10. Stelara (ustekinumab)
    11. FDA Stelara

    Disclaimer: This article is not meant to influence or impact the care provided by your treating physician. Please do not make changes to your treatment without first consulting your healthcare provider. This article is not intended to diagnose or treat illness or to influence treatment options. TheSocialMedwork is as diligent as possible in compiling and updating the information on this page. However, TheSocialMedwork does not guarantee the correctness and completeness of the information provided on this page.